Cancer Letters 2015-09-28

Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer

Tomohiro Yonezawa, Kuan-Hui (Ethan) Chen, Mrinal K. Ghosh, Lorena Rivera, Riva Dill, Lisa Ma, Pedro A. Villa, Mitsumori Kawaminami, Ameae M. Walker

Index: Cancer Lett. 366 , 84-92, (2015)

Full Text: HTML

Abstract

• The work establishes a crucial role for the long prolactin receptor in metastatic spread of breast cancer. • The spice-modulating agent has potential as a well-tolerated cancer therapeutic. • The principle of isoform-specific knockdown can be applied to multiple targets in breast and other cancers.

Related Compounds

Structure Name/CAS No. Articles
beta-Estradiol Structure beta-Estradiol
CAS:50-28-2
Formaldehyde Structure Formaldehyde
CAS:50-00-0
Progesterone Structure Progesterone
CAS:57-83-0
Prolactin, Human Pituitary, Iodination Grade Structure Prolactin, Human Pituitary, Iodination Grade
CAS:9002-62-4
Ethylenediaminetetraacetic acid Structure Ethylenediaminetetraacetic acid
CAS:60-00-4